Physician profile
Frank Roy Albano
NPI 1982870986
$36,702.23
in general payments reported to CMS, 2019-2025
46 companies · $19K in 2025
The $19K reported for 2025 was more than what 99% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,904 · 2022: $2,647 · 2023: $3,638 · 2024: $9,401 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,538 · Travel and Lodging: $2,754 · Consulting Fee: $2,379 · Honoraria: $2,320 · Education: $28.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17,131.89 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,537.50 |
| Travel and Lodging | $2,754.26 |
| Consulting Fee | $2,378.75 |
| Honoraria | $2,320.00 |
| Education | $28.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cequr Corporation | $9,037.80 | 2022-2025 | Cequr Simplicity |
| Sequel Med Tech, LLC | $4,184.04 | 2025 | Twiist |
| Mannkind Corporation | $3,464.03 | 2022-2025 | Afrezza |
| Radius Health, INC. | $2,964.42 | 2021-2025 | Tymlos |
| Dexcom, INC. | $2,082.14 | 2022-2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $2,069.12 | 2023-2025 | Minimed 780g, Micra, Linq II |
| Lilly USA, LLC | $1,674.24 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $1,580.98 | 2021-2025 | |
| Xeris Pharmaceuticals, INC. | $1,333.86 | 2021-2025 | Recorlev, Gvoke Hypopen |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,106.38 | 2021-2024 | Jardiance, Tradjenta, Synjardy |
| Sanofi-Aventis U.S. LLC | $966.33 | 2021-2024 | |
| Novo Nordisk INC | $900.75 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $608.98 | 2022-2025 | Evenity, Tepezza, Prolia |
| Astrazeneca Pharmaceuticals Lp | $536.42 | 2021-2023 | Farxiga |
| Intuity Medical INC | $459.29 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $395.84 | 2021-2025 | Freestyle Libre 3 |
| Corcept Therapeutics | $264.91 | 2021-2025 | Korlym |
| Abbvie INC. | $262.17 | 2021-2024 | |
| Alexion Pharmaceuticals, INC. | $253.15 | 2023-2025 | Strensiq |
| Intra-Sana Laboratories | $227.83 | 2023-2024 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Madrigal Pharmaceuticals | $226.16 | 2025 | Rezdiffra |
| Amneal Pharmaceuticals LLC | $217.74 | 2023-2025 | Unithroid |
| Nevro Corp. | $177.54 | 2021-2022 | |
| Insulet Corporation | $170.84 | 2023-2025 | Omnipod |
| Kyowa Kirin, INC. | $152.78 | 2024 | Crysvita |
| Ascendis Pharma Endocrinology INC | $148.28 | 2025 | Yorvipath |
| Amryt Pharma Holdings Ltd | $137.71 | 2022 | |
| Recordati_rare_diseases_inc. | $135.34 | 2022-2025 | Isturisa |
| Axsome Therapeutics, INC. | $129.59 | 2023 | Sunosi |
| Tolmar, INC. | $124.24 | 2024 | |
| Tandem Diabetes Care, INC. | $113.01 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Amphastar Pharmaceuticals, INC. | $97.22 | 2023-2025 | Baqsimi |
| Pfizer INC. | $89.97 | 2022-2024 | |
| Amarin Pharma, INC. | $84.32 | 2021-2022 | |
| Verity Pharmaceuticals INC. | $70.76 | 2024-2025 | Tlando |
| Ibsa Pharma INC. | $40.63 | 2021-2022 | |
| Eusa Pharma (US) LLC | $32.86 | 2022 | |
| Bigfoot Biomedical INC | $28.29 | 2022 | |
| Ascensia Diabetes Care US INC. | $23.69 | 2025 | |
| Novartis Pharmaceuticals Corporation | $21.85 | 2022 | |
| Zealand Pharma US, INC. | $20.72 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.34 | 2023 | Cycloset |
| Merck Sharp & Dohme LLC | $18.07 | 2021 | |
| Acerus Pharmaceuticals Corporation | $18.02 | 2022 | |
| Antares Pharma, INC. | $16.68 | 2022 | |
| Endo USA, INC. | $13.90 | 2025 | Aveed |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Albano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.